Physician profile
Nisha Gupta
NPI 1659665263
$3,824.53
in general payments reported to CMS, 2019-2025
18 companies · $79.15 in 2025
The $79.15 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,451 · 2020: $198 · 2021: $1,779 · 2022: $102 · 2023: $145 · 2024: $70.94 · 2025: $79.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $1,523.23 | 2021 | |
| Novartis Pharmaceuticals Corporation | $505.99 | 2019-2021 | |
| Allergan, INC. | $384.77 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $262.77 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $212.81 | 2019-2021 | |
| Spark Therapeutics, INC. | $124.55 | 2019 | |
| Eyepoint US, INC. | $122.08 | 2020 | |
| Horizon Therapeutics Plc | $116.73 | 2023 | Tepezza |
| Alcon Vision LLC | $116.10 | 2019 | |
| Abbvie INC. | $101.65 | 2022 | |
| Merck Sharp & Dohme LLC | $89.62 | 2024-2025 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Johnson & Johnson Surgical Vision, INC. | $85.87 | 2019 | |
| Cardiovascular Systems INC. | $43.44 | 2020 | |
| Mallinckrodt Hospital Products INC. | $36.12 | 2020-2021 | |
| Genentech USA, INC. | $33.63 | 2025 | Vabysmo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $28.07 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $26.84 | 2025 | Neffy |
| Optos, INC. | $10.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nisha Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.